<- Go Home
Collagen Aesthetics, Inc.
As of September 1, 1999, Collagen Aesthetics, Inc. was acquired by Allergan Medical. Collagen Aesthetics, Inc. is engaged in the design, development, manufacture, and marketing of biomedical devices for the treatment of defective, diseased, traumatized or aging human tissues. The company's products are used principally in facial aesthetic applications and the treatment of stress urinary incontinence. The company markets its facial aesthetic products directly and through a network of international distributors, and its stress urinary incontinence product through a marketing partner. The company is based in Palo Alto, California.
Market Cap
$138.6M
Volume
35.4K
Cash and Equivalents
$15.8M
EBITDA
-$4.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$56.8M
Profit Margin
69.83%
52 Week High
$16.31
52 Week Low
$7.25
Dividend
N/A
Price / Book Value
1.31
Price / Earnings
37.73
Price / Tangible Book Value
1.48
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$11.1M
Return on Equity
3.16%
Return on Assets
-3.99
Cash and Short Term Investments
$18.3M
Debt
N/A
Equity
$110.7M
Revenue
$81.4M
Unlevered FCF
-$1.1M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium